pillbase.ru

Myalepta

Active substance: metreleptin

Metreleptin

Centralised EU authorisationActive

Marketing holder: Chiesi Farmaceutici S.p.A.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • Myalept
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · METRELEPTIN 11.3 mg/2.2mL
    10122-210
    Chiesi USA, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208f-7f39-7d33-bbef-9790a8a77f18;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004218
Registration status
Active
ATC code
A16AA
Sources
  • product · EMA · EMEA/H/C/004218 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004218 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004218 · Verified 2026-10-09